A novel mu-opioid receptor agonist showed strong analgesia without respiratory depression, tolerance, or significant ...

Doctors in multiple states report unpaid claims and care delays under the new federal program, as a lawsuit seeks answers about AI algorithms and data security.

Many researchers prefer the “live” data that comes from real-world results while still acknowledging potential shortcomings.

State bans on conversion therapy remain enforceable after the US Supreme Court’s ruling, but experts warn the decision may invite new legal challenges.

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in RRMS may affect ...

Dr Chu-Yueh Guo prepares to discover how the latest diagnostic criteria and breakthrough treatments are reshaping the ...

"I find the consistency across age, race, BMI, and glycemic status more clinically exciting than the sex difference," said ...

In allogeneic haematopoietic cell transplant recipients, ciprofloxacin prophylaxis may reduce bloodstream infections but is ...

Under NICE’s final draft guidance, vorasidenib (Voranigo, Servier Laboratories) is indicated for patients with grade 2 astrocytoma or oligodendroglioma with susceptible isocitrate dehydrogenase (IDH1 ...

Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.

Clinicians can reasonably include Mediterranean-style eating in respiratory prevention counseling — alongside smoking ...

Continuous glucose monitoring is expanding beyond type 1 diabetes, offering detailed glycemic insights that may support earlier intervention in patients with type 2 diabetes.